Write your message
Volume 7, Issue 3 (May & June - Volume 07 - Issue 03 2022)                   J Obstet Gynecol Cancer Res 2022, 7(3): 256-257 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karpians G, Piranfar V, Karami M. Interleukin 6 (IL-6) in Patient with COVID-19 Infection: The Cross-Sectional Study. J Obstet Gynecol Cancer Res. 2022; 7 (3) :256-257
URL: http://jogcr.com/article-1-510-en.html
1- Department of Biochemistry, Medical Laboratory, Tehran, Iran
2- Research and Development Department, Farname Inc, Thornhill, Canada , vahab.p@gmail.com
3- Department of Molecular Biology, Medical Laboratory, Tehran, Iran
Abstract:   (113 Views)

To update data published in the article “Leukocytes Parameters, CRP, and Ferritin in Iranian Patients with COVID-19 Infection; A Cross-sectional Study” in Iran J Med Microbiol 2021, 15(3): 361-368, we analyzed the IL-6 parameter in the aforementioned article’s statistical population. The analyzed results showed that IL-6 parameter had increased more in men and women infected by SARS-CoV-2 (76.7% and 87.3%, respectively) compared with normal people (up to 5.9 pg/mL).

Full-Text [PDF 168 kb]   (14 Downloads) |   |   Full-Text (HTML)  (12 Views)  
Systematic Review: Letter to the Editor | Subject: Pathology
Received: 2021/11/3 | Accepted: 2021/12/9 | Published: 2022/01/12

References
1. Karpians G, Piranfar V, Yahyavi I, Sepanian T, Sepanian T, Alizadeh S, et al. Leukocytes Parameters, CRP, and Ferritin in Iranian Patients with COVID-19 Infection; A Cross-sectional Study. Iran J Med Microbiol. 2021;15(3):361-8. [DOI:10.30699/ijmm.15.3.361]
2. Jones SA, Hunter CA. Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol. 2021;21(6):337-9. [DOI:10.1038/s41577-021-00553-8] [PMID] [PMCID]
3. Nasonov E, Samsonov M. The role of Interleukin 6 inhibitors in therapy of severe COVID-19. Biomed Pharmacother. 2020:110698. [DOI:10.1016/j.biopha.2020.110698] [PMID] [PMCID]
4. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [DOI:10.1001/jama.2020.2648] [PMID]
5. Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, et al. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020;34(2):333-8. [DOI:10.23812/editorial-conti-2] [PMID] [PMCID]
6. Tkacova R. Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm. 2010;2010:585989. [DOI:10.1155/2010/585989] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.